Enliven Therapeutics, Inc. (ELVN)
1 Item 5.02 filing since 2026-10-14 · roles: Director. Nasdaq. Pharmaceutical Preparations. State: CA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-10-14 | Board election | Director | subscribers | — | Enliven Therapeutics, Inc. (ELVN): director Kristine Ball elected to the board |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works